BRANDI JOHNSTON: Open Payments
NPI 1497271415 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,789 in 124 payments from 21 companies in 2025. Trend: 2023 $1,080 · 2024 $2,852 · 2025 $2,789
Food & beverage: $2,771Education: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $385 |
| PFIZER INC. | 17 | $296 |
| Alexion Pharmaceuticals, Inc. | 8 | $262 |
| ACADIA Pharmaceuticals Inc | 10 | $242 |
| SK Life Science, Inc. | 8 | $240 |
| Neurocrine BioSciences, Inc. | 7 | $195 |
| UCB, Inc. | 9 | $191 |
| ARGENX US, INC. | 7 | $186 |
| Lundbeck LLC | 13 | $182 |
| Merz Pharmaceuticals, LLC | 5 | $154 |
Products named: NURTEC ODT, BOTOX, ULTOMIRIS, NUPLAZID, INGREZZA, VYVGART HYTRULO, Xeomin, LEQEMBI.
Industry payments across MS — which companies pay providers there.
